Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003269-15Phase 4Terminated
Phase 4, randomised trial of insulin aspart and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Karolinska University Hospital. Primary endpoint: Glycemic control (HbA1c after 20 weeks). Started Jul 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003269-15.